Cubist Systematic Strategies’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Cubist Systematic Strategies’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,396	Closed	-$217K	–	2046
2016 Q3	$217K	Buy	10,396 +10,296	+10,296%	+$119K	0.01%	1209
2016 Q2	$1K	Buy	100 +11	+12%	+$94	﹤0.01%	1694
2016 Q1	$1K	Buy	+89	New	+$809	﹤0.01%	1576
2015 Q2	–	Sell	-1,200	Closed	-$14K	–	2217
2015 Q1	$14K	Buy	+1,200	New	+$16.2K	﹤0.01%	1825

Cubist Systematic Strategies's VTAE Position: Q4 2016 in Review

Cubist Systematic Strategies sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 10,396 shares — an estimated $217K sold.

Cubist Systematic Strategies first reported a position in VTAE in Q1 2015 and held it in 4 quarters. The position peaked at $217K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Cubist Systematic Strategies reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Cubist Systematic Strategies sold 10,396 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $217K.
Cubist Systematic Strategies first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 4 quarters.
Cubist Systematic Strategies's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $217K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Cubist Systematic Strategies's 13F filing for Q4 2016, filed 14 Feb 2017.